TrialCancer2026

Durvalumab combined with concurrent chemoradiotherapy in patients with limited-stage small cell lung cancer: A prospective, single-arm, phase 2 clinical trial.

Chunyang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.